Fatty Acids can Substitute the HIV Fusion Peptide in Lipid Merging and Fusion: An Analogy between Viral and Palmitoylated Eukaryotic Fusion Proteins

Journal of Molecular Biology

Volumn 374, Issue 1, 2007, Pages 220-230

  Lev, Naama ^a   Shai, Yechiel ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

AFM; fusion peptide; HIV 1 gp41; membrane fusion; peptide lipid interaction

Indexed keywords

FATTY ACID; HIV FUSION PEPTIDE; HYBRID PROTEIN; LIPID; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN;

ACYLATION; AMINO ACID SUBSTITUTION; ARTICLE; ATOMIC FORCE MICROSCOPY; EUKARYOTIC CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROPHOBICITY; MEMBRANE BINDING; PALMITOYLATION; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PURIFICATION;

EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 35348957822     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2007.09.008     Document Type: Article

References (59)

1. Korazim O., Sackett K., and Shai Y. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended. J. Mol. Biol. 364 (2006) 1103-1117
2. Veronese F.D., DeVico A.L., Copeland T.D., Oroszlan S., Gallo R.C., and Sarngadharan M.G. Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. Science 229 (1985) 1402-1405
3. Center R.J., Leapman R.D., Lebowitz J., Arthur L. O., Earl P.L., and Moss B. Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J. Virol. 76 (2002) 7863-7867
4. Rabenstein M., and Shin Y.K. A peptide from the heptad repeat of human immunodeficiency virus gp41 shows both membrane binding and coiled-coil formation. Biochemistry 34 (1995) 13390-13397
5. Backer J.M., and Dawidowicz E.A. Reconstitution of a phospholipid flippase from rat liver microsomes. Nature 327 (1987) 341-343
6. Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W.C., Terwilliger E., et al. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237 (1987) 1351-1355
7. Martin I., Schaal H., Scheid A., and Ruysschaert J.M. Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer. J. Virol. 70 (1996) 298-304
8. Jones P.L., Korte T., and Blumenthal R. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors. J. Biol. Chem. 273 (1998) 404-409
9. Melikyan G.B., Egelhofer M., and von Laer D. Membrane-anchored inhibitory peptides capture human immunodeficiency virus type 1 gp41 conformations that engage the target membrane prior to fusion. J. Virol. 80 (2006) 3249-3258
10. Furuta R.A., Wild C.T., Weng Y., and Weiss C.D. Capture of an early fusion-active conformation of HIV-1 gp41. Nature Struct. Biol. 5 (1998) 276-279
11. Munoz-Barroso I., Durell S., Sakaguchi K., Appella E., and Blumenthal R. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41. J. Cell. Biol. 140 (1998) 315-323
12. Chan D.C., Fass D., Berger J.M., and Kim P.S. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89 (1997) 263-273
13. Weissenhorn W., Dessen A., Harrison S.C., Skehel J. J., and Wiley D.C. Atomic structure of the ectodomain from HIV-1 gp41. Nature 387 (1997) 426-430
14. Markosyan R.M., Cohen F.S., and Melikyan G.B. HIV-1 envelope proteins complete their folding into six-helix bundles immediately after fusion pore formation. Mol. Biol Cell. 14 (2003) 926-938
15. Schaal H., Klein M., Gehrmann P., Adams O., and Scheid A. Requirement of N-terminal amino acid residues of gp41 for human immunodeficiency virus type 1-mediated cell fusion. J. Virol. 69 (1995) 3308-3314
16. Freed E.O., Delwart E.L., Buchschacher Jr. G.L., and Panganiban A.T. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl Acad. Sci. USA 89 (1992) 70-74
17. Delahunty M.D., Rhee I., Freed E.O., and Bonifacino J. S. Mutational analysis of the fusion peptide of the human immunodeficiency virus type 1: identification of critical glycine residues. Virology 218 (1996) 94-102
18. Pritsker M., Rucker J., Hoffman T.L., Doms R.W., and Shai Y. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes. Biochemistry 38 (1999) 11359-11371
19. Dimitrov A.S., Rawat S.S., Jiang S., and Blumenthal R. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion. Biochemistry 42 (2003) 14150-14158
20. Durell S.R., Martin I., Ruysschaert J.M., Shai Y., and Blumenthal R. What studies of fusion peptides tell us about viral envelope glycoprotein-mediated membrane fusion (review). Mol. Membr. Biol. 14 (1997) 97-112
21. Tamm L.K., and Han X. Viral fusion peptides: a tool set to disrupt and connect biological membranes. Biosci. Rep. 20 (2000) 501-518
22. Pallavi B., and Nagaraj R. Palmitoylated peptides from the cysteine-rich domain of SNAP-23 cause membrane fusion depending on peptide length, position of cysteines, and extent of palmitoylation. J. Biol. Chem. 278 (2003) 12737-12744
23. Veit M., Laage R., Dietrich L., Wang L., and Ungermann C. Vac8p release from the SNARE complex and its palmitoylation are coupled and essential for vacuole fusion. EMBO J. 20 (2001) 3145-3155
24. Salzwedel K., West J.T., and Hunter E. A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. J. Virol. 73 (1999) 2469-2480
25. Munoz-Barroso I., Salzwedel K., Hunter E., and Blumenthal R. Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion. J. Virol. 73 (1999) 6089-6092
26. Peisajovich S.G., Epand R.F., Pritsker M., Shai Y., and Epand R.M. The polar region consecutive to the HIV fusion peptide participates in membrane fusion. Biochemistry 39 (2000) 1826-1833
27. Suarez T., Gallaher W.R., Agirre A., Goni F.M., and Nieva J.L. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion. J. Virol. 74 (2000) 8038-8047
28. Sackett K., and Shai Y. The HIV-1 gp41 N-terminal heptad repeat plays an essential role in membrane fusion. Biochemistry 41 (2002) 4678-4685
29. Wexler-Cohen Y., Sackett K., and Shai Y. The role of the N-terminal heptad repeat of HIV-1 in the actual lipid mixing step as revealed by its substitution with distant coiled coils. Biochemistry 44 (2005) 5853-58561
30. Pascual R., Moreno M.R., and Villalain J. A peptide pertaining to the loop segment of human immunodeficiency virus gp41 binds and interacts with model biomembranes: implications for the fusion mechanism. J. Virol. 79 (2005) 5142-5152
31. Pascual R., Contreras M., Fedorov A., Prieto M., and Villalain J. Interaction of a peptide derived from the N-heptad repeat region of gp41 Env ectodomain with model membranes. Modulation of phospholipid phase behavior. Biochemistry 44 (2005) 14275-14288
32. Moreno M.R., Giudici M., and Villalain J. The membranotropic regions of the endo and ecto domains of HIV gp41 envelope glycoprotein. Biochim. Biophys. Acta 1758 (2006) 111-123
33. Kliger Y., Peisajovich S.G., Blumenthal R., and Shai Y. Membrane-induced conformational change during the activation of HIV-1 gp41. J. Mol. Biol. 301 (2000) 905-914
34. Epand R.F., Macosko J.C., Russell C.J., Shin Y.K., and Epand R.M. The ectodomain of HA2 of influenza virus promotes rapid pH dependent membrane fusion. J. Mol. Biol. 286 (1999) 489-503
35. Ghosh J.K., and Shai Y. Direct evidence that the N-terminal heptad repeat of Sendai virus fusion protein participates in membrane fusion. J. Mol. Biol. 292 (1999) 531-546
36. White J.M. Viral and cellular membrane fusion proteins. Annu. Rev. Physiol. 52 (1990) 675-697
37. 13C FTIR study. J. Mol. Biol. 350 (2005) 790-805
38. Glick B.S., and Rothman J.E. Possible role for fatty acyl-coenzyme A in intracellular protein transport. Nature 326 (1987) 309-312
39. Pfanner N., Glick B.S., Arden S.R., and Rothman J.E. Fatty acylation promotes fusion of transport vesicles with Golgi cisternae. J. Cell Biol. 110 (1990) 955-961
40. Sakai T., Ohuchi R., and Ohuchi M. Fatty acids on the A/USSR/77 influenza virus hemagglutinin facilitate the transition from hemifusion to fusion pore formation. J. Virol. 76 (2002) 4603-4611
41. Quintana F.J., Gerber D., Kent S.C., Cohen I.R., and Shai Y. HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation. J. Clin. Invest. 115 (2005) 2149-2158
42. Bloch I., Quintana F.J., Gerber D., Cohen T., Cohen I.R., and Shai Y. T-cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif. FASEB J. 21 (2007) 393-401
43. Sackett K., and Shai Y. How structure correlates to function for membrane associated HIV-1 gp41 constructs corresponding to the N-terminal half of the ectodomain. J. Mol. Biol. 333 (2003) 47-58
44. Wild C., Dubay J.W., Greenwell T., Baird Jr. T., Oas T.G., McDanal C., et al. Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex. Proc. Natl Acad. Sci. USA 91 (1994) 12676-12680
45. Jiang S., Lin K., Strick N., and Neurath A.R. HIV-1 inhibition by a peptide. Nature 365 (1993) 113
46. Dubay J.W., Roberts S.J., Brody B., and Hunter E. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity. J. Virol. 66 (1992) 4748-4756
47. Poumbourios P., Wilson K.A., Center R.J., El Ahmar W., and Kemp B.E. Human immunodeficiency virus type 1 envelope glycoprotein oligomerization requires the gp41 amphipathic alpha-helical/leucine zipper-like sequence. J. Virol. 71 (1997) 2041-2049
48. Chen S.S., Lee C.N., Lee W.R., McIntosh K., and Lee T.H. Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J. Virol. 67 (1993) 3615-3619
49. Chen S.S. Functional role of the zipper motif region of human immunodeficiency virus type 1 transmembrane protein gp41. J. Virol. 68 (1994) 2002-2010
50. Dimitrov A.S., Louis J.M., Bewley C.A., Clore G.M., and Blumenthal R. Conformational changes in HIV-1 gp41 in the course of HIV-1 envelope glycoprotein-mediated fusion and inactivation. Biochemistry 44 (2005) 12471-12479
51. Driesen R.B., Dispersyn G.D., Verheyen F.K., van den Eijnde S.M., Hofstra L., Thone F., et al. Partial cell fusion: a newly recognized type of communication between dedifferentiating cardiomyocytes and fibroblasts. Cardiovasc. Res. 68 (2005) 37-46
52. Van den Eijnde S.M., Van den Hoff M.J., Reutelingsperger C.P., Van Heerde W.L., Henfling M.E., Vermeij-Keers C., et al. Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J. Cell Sci. 114 (2001) 3631-3642
53. Gautier I., Coppey J., and Durieux C. Early apoptosis-related changes triggered by HSV-1 in individual neuronlike cells. Exp. Cell Res. 289 (2003) 174-183
54. Struck D.K., Hoekstra D., and Pagano R.E. Use of resonance energy transfer to monitor membrane fusion. Biochemistry 20 (1981) 4093-4099
55. Yang T., Simanek E.E., and Cremer P. Creating addressable aqueous microcompartments above solid supported phospholipid bilayers using lithographically patterned poly(dimethylsiloxane) molds. Anal. Chem. 72 (2000) 2587-2589
56. Jameson D.M., and Sawyer W.H. Fluorescence anisotropy applied to biomolecular interactions. Methods Enzymol. 246 (1995) 283-300
57. Surewicz W.K., Mantsch H.H., and Chapman D. Determination of protein secondary structure by Fourier transform infrared spectroscopy: a critical assessment. Biochemistry 32 (1993) 389-394
58. Vigano C., Goormaghtigh E., and Ruysschaert J.M. Detection of structural and functional asymmetries in P-glycoprotein by combining mutagenesis and H/D exchange measurements. Chem. Phys. Lipids 122 (2003) 121-135
59. Wu C.S., Ikeda K., and Yang J.T. Ordered conformation of polypeptides and proteins in acidic dodecyl sulfate solution. Biochemistry 20 (1981) 566-570